The effect of Lansoprazole in the prevention of osteonecrosis of the femoral head in patients with immune diseases treated corticosteroid

Trial Profile

The effect of Lansoprazole in the prevention of osteonecrosis of the femoral head in patients with immune diseases treated corticosteroid

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Lansoprazole (Primary) ; Lansoprazole (Primary)
  • Indications Osteonecrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top